|
|
Volumn 199, Issue 3, 2005, Pages 253-265
|
|
The Bcl-2 family of proteins as drug targets;Antagonistes de Bcl-2, thérapies anticancéreuses alternatives.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
APOPTOSIS REGULATORY PROTEIN;
FLAVONOID;
OLIGOPEPTIDE;
PHENOL DERIVATIVE;
POLYPHENOLS;
PROTEIN BCL 2;
APOPTOSIS;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG DESIGN;
DRUG EFFECT;
GENE THERAPY;
GENETICS;
HUMAN;
MULTIGENE FAMILY;
NEOPLASM;
NUCLEIC ACID PROBE;
PATHOLOGY;
PHYSIOLOGY;
PROTEIN CONFORMATION;
PROTEIN TERTIARY STRUCTURE;
PROTO ONCOGENE;
REVIEW;
STRUCTURE ACTIVITY RELATION;
ANTINEOPLASTIC AGENTS;
ANTISENSE ELEMENTS (GENETICS);
APOPTOSIS;
APOPTOSIS REGULATORY PROTEINS;
DRUG DESIGN;
FLAVONOIDS;
GENE THERAPY;
GENES, BCL-2;
HUMANS;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
MULTIGENE FAMILY;
NEOPLASMS;
OLIGOPEPTIDES;
PHENOLS;
PROTEIN CONFORMATION;
PROTEIN STRUCTURE, TERTIARY;
PROTO-ONCOGENE PROTEINS C-BCL-2;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 33645092424
PISSN: 12950661
EISSN: None
Source Type: Journal
DOI: 10.1051/jbio:2005027 Document Type: Review |
|
Times cited : (11)
|
|
References (117)
|
